Fu H, Huang J, Zhao T, Wang H, et al. Fibroblast Activation Protein-Targeted Radioligand Therapy with 177Lu-EB-FAPI for Metastatic Radioiodine Refractory Thyroid Cancer: First-in-Human, Dose-Escalation Study. Clin Cancer Res 2023 Oct 6. doi: 10.1158/1078-0432.CCR-23-1983.
PMID: 37801296